Measuring Outcomes of Maternal COVID-19-related Prenatal Exposure

Plain-language summary

This study evaluated the outcomes of exposure to COVID-19-related maternal stress during pregnancy on infants. It enrolled mothers over age 18 without prenatal pathology and newborns with a gestational age of 37 weeks or more. This is a study without an assigned phase and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

IRCCS National Neurological Institute "C. Mondino" Foundation

Intervention

Maternal stress

Start date

5/6/2020

Estimated completion

5/15/2024

Countries

Italy

Related genes

Locations

• Pavia, Italy

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Italian nationality or full mastery of Italian language to access on-line questionnaires without support
* No prenatal pathologies or perinatal risks
* Maternal age higher than 18 years
* Newborns' gestational age equal or higher than 37 weeks

Exclusion Criteria:

* Single-parent mothers
* Medically assisted conception
* Infants' genetic or metabolic comorbidities
* Perinatal injuries or sensorial deficits